Dr. Faran Naim

Dr. Faran Naim

Consultant 

15 Years of Experience

Bone Marrow Transplant Surgeon, Hemato-Oncologist, Pediatric Hematologist

MBBS, MD, DNB

Reg. No.:75306, Delhi Medical Council

Max Super Speciality Hospital, Saket, New Delhi

Max Smart Super Speciality Hospital, Saket, New Delhi

English, Hindi

Consultation Fee ₹ 1500

Book an Appointment

About Dr. Faran Naim

  • Dr. Faran Naim is a prominent Hemato-oncologist and Bone Marrow Transplant Specialist in New Delhi.
  • He has over 15 years of experience and specializes in pediatric hematology. 
  • His areas of expertise include diagnosing and managing leukemia, lymphoma, chronic anemia, platelet disorders, thalassemia, hemophilia, bleeding, and coagulation disorders.
  • Dr. Naim completed his MBBS from Madras Medical College in 2009 and his MD in Internal Medicine from MLB Medical College, Jhansi, in 2015.
  • Later, in 2019, he specialized in blood disorders by pursuing a DNB in Clinical Hematology from Sir Ganga Ram Hospital, New Delhi.
  • Dr. Naim has actively participated in research and development in the field of hematology. His articles have been published in renowned journals such as the South Asian Journal of Cancer and the Indian Journal of Hematology and Blood Transfusion.
  • He is a member of the Delhi Society of Hematology and the Indian Society of Oncology.

Book Your Appointment With Dr. Faran Naim

Get a Treatment Plan Within 1 Hour

Education

  • MBBS, Madras Medical College, 2009
  • MD (Internal Medicine), MLB Medical College, Jhansi, 2015
  • DNB (Clinical Hematology), Sir Ganga Ram Hospital, New Delhi, 2019

Past Experience

  • Specialist (Malignant Hematology), Kuwait Cancer Control Centre, Kuwait
  • Senior Consultant (Clinical Hematology), Metro Hospital, Faridabad
  • Senior Consultant (Clinical Hematology), Sarvodaya Hospital, Faridabad
  • Attending Consultant (Hematology and Bone Marrow Transplant Unit), Rajeev Gandhi Cancer Institute, New Delhi
  • Senior Resident (Hematology), Sir Ganga Ram Hospital, New Delhi

Awards

  • Dr. Faran Naim was awarded the Best Paper Award at the 29th Annual Delhi Society of Hematology Conference.

Associations/Membership

  • Delhi Society of Hematology
  • Indian Society of Oncology

Paper Published

  • Rainchwar, Sujay & Naim, Faran & Panda, Tribikram & Shaikh, Mohd & Chand, Rashmi & Soni, Mayank & Halder, Rohan & Bhurani, Dinesh & Agrawal, Narendra & Ahmed, Rayaz. (2024). Haploidentical HSCT With Fludarabine, Melphalan 75 mg/m2, and 400 cGy TBI: A Tolerable Conditioning Regimen With Low Toxicity and Good Anti-Leukemic Activity. Clinical Lymphoma Myeloma and Leukemia. 24. S254. 10.1016/S2152-2650(24)01073-5. 
  • Rainchwar, Sujay & Naim, Faran & Panda, Tribikram & Shaikh, Mohd & Chand, Rashmi & Soni, Mayank & Halder, Rohan & Dinesh, Dinesh & Agrawal, Narendra & Rayaz, Rayaz. (2024). CT-678 Haploidentical HSCT With Fludarabine, Melphalan 75 mg/m2 and 400 cGy TBI: A Tolerable Conditioning Regimen With Low Toxicity and Good Anti-Leukemic Activity. Clinical Lymphoma Myeloma and Leukemia. 24. S613-S614. 10.1016/S2152-2650(24)01794-4. 
  • Mandal, Saikat & Naim, Faran & Kumar, Ranjan & Gupta, Sumant & Gupta, Vibhu & Kathuria, Ishita. (2022). A pilot study on the impact of the use of medium molecular weight hydroxyethyl starch in granulocyte apheresis using Spectra Optia. Transfusion and Apheresis Science. 61. 10.1016/j.transci.2022.103436. 
  • Gupta, Sumant & Pandey, Anamika & Gupta, Neha & Naim, Faran & Gupta, Rakesh & Das, Bhaskar. (2021). Increase in Cancer Patient Load during COVID-19 Pandemic: The Faridabad Experience. South Asian journal of cancer. 10. 36-38. 10.1055/s-0041-1726159. 
  • Gupta, Sumant & Gupta, Neha & Naim, Faran & Minz, Arvind. (2021). COVID-19 Second Wave—The Tsunami and the Collapsing Indian Health Care Scene. Is Bevacizumab Strong Enough to Hold Fort? South Asian Journal of Cancer. 10. 48-48. 10.1055/s-0041-1733319. 
  • Kapoor, Jyotsna & Khushoo, Vishvdeep & Garg, Ambar & Naim, Faran & Bhatia, Niharika & Folbs, Bhaarat & Mehta, Pallavi & Ahmed, Rayaz & Agrawal, Narendra & Bhurani, Dinesh & Mirgh, Sumeet. (2021). An “impossible” harvest–GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma. Bone Marrow Transplantation. 56. 1-3. 10.1038/s41409-021-01256-3. 
  • Kapoor, Jyotsna & Kumar, Suman & Agrawal, Pragya & Khushoo, Vishvdeep & Naim, Faran & Mirgh, Sumeet & Ahmed, Rayaz & Bhurani, Dinesh & Agrawal, Narendra. (2020). Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high-risk ALL. Bone Marrow Transplantation. 55. 10.1038/s41409-020-0898-1. 
  • Singh, Reema & Kapoor, Jyotsna & Agrawal, Narendra & Ahmed, Rayaz & Agrawal, Pragya & Khushoo, Vishvdeep & Naim, Faran & Bhurani, Dinesh. (2020). Preferred Mode: Poster Category: Hemato-Oncology Upfront Nilotinib in Chronic Myeloid Leukemia: a single-center experience. 
  • Bhatia, Pratibha & Mirgh, Sumeet & Khushoo, Vishvdeep & Naim, Faran & Garg, Ambar & Ahmed, Rayaz & Agrawal, Narendra & Bhurani, Dinesh. (2019). Effect of Depression on Health-Related Quality of Life and Adherence and Its Correlation with Response Rates in Patients of Chronic Myeloid Leukemia on First Line Imatinib and Nilotinib - a Prospective, Institutional Analysis of Real World Data from India. Blood. 134. 3500-3500. 10.1182/blood-2019-131763. 
  • Mirgh, Sumeet & Kapoor, Jyotsna & Francis Thekkudan, Shinto & Khushoo, Vishvdeep & Naim, Faran & Garg, Ambar & Agrawal, Narendra & Ahmed, Rayaz & Bhurani, Dinesh. (2019). Combination of Venetoclax and Hypomethylating Agents in Myeloid Malignancies in Patients Unfit for Intensive Chemotherapy - Real World Data from a Tertiary Care Centre in India. Is it time to bid Adieu 3+7? Blood. 134. 5149-5149. 10.1182/blood-2019-131746. 
  • Naim, Faran & Saraf, Amrita & Dass, Jasmita & Arya, Vandana & Langer, Sabina & Gupta, Nitin & Sharma, Ajay & Kotwal, Jyoti. (2019). A Prospective, Cross-Sectional Study of PNH Clone in MDS Patients Using High Sensitivity Flowcytometry: A Single Center Experience. Indian Journal of Hematology and Blood Transfusion. 36. 10.1007/s12288-019-01219-1. 
  • Singh, Reema & Panwar, Nisha & Mirgh, Sumeet & Kapoor, Jyotsna & Khushoo, Vishvdeep & Naim, Faran & Agrawal, Pragya & Agrawal, Narendra & Bhurani, Dinesh & Ahmed, Rayaz. (2019). HIV Associated Lymphomas: A Double-Edged Sword -A Retrospective Institutional Experience.
  • Mirgh, Sumeet & Ahmed, Rayaz & Agrawal, Narendra & Kapoor, Jyotsna & Yadav, Neha & Khushoo, Vishvdeep & Bhatia, Niharika & Garg, Ambar & Naim, Faran & Bhurani, Dinesh. (2019). Impact of Pre-Transplant and Post-Transplant Responses on Outcomes and Survival in Multiple Myeloma. Blood Research. 54. 341. 

Field of Expertise

  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
  • Haplo–Allogeneic Bone Marrow Transplant
  • Hematopoietic Stem Cell Transplantation (HPSCT)
  • Pediatric Bone Marrow Transplant
  • Stem Cell Transplant
  • Anemia
  • Aplastic Anemia
  • Chronic Granulomatous Disease (CGD)
  • Diamond-Blackfan Anemia (DBA)
  • Dyskeratosis Congenita (DKC)
  • Eosinophilic Disorders
  • Essential Thrombocythemia
  • Fanconi Anemia (FA)
  • Hemochromatosis
  • Hemolytic Anemia
  • Hemophilia
  • Hereditary Spherocytosis
  • Hodgkin Lymphoma
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Inherited Bone Marrow Failure Syndromes (IBMFS)
  • Iron-Deficiency Anemia
  • Langerhans Cell Histiocytosis (LHC)
  • Leukopenia
  • Mastocytosis
  • Monoclonal Gammopathy
  • Myelodysplastic Syndromes (MDS)
  • Myelofibrosis
  • Myeloproliferative Neoplasms (MPN)
  • Non-Hodgkin Lymphoma
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pernicious Anemia
  • Polycythemia Vera
  • Porphyria
  • Post-Transplant Lymphoproliferative Disorder (PTLD)
  • Shwachman-Diamond syndrome (SDS)
  • Sickle Cell Anemia
  • Thalassemia
  • Thrombocytopenia
  • Thrombophilia
  • Thrombotic Thrombocytopenic Purpura (TTP)
  • Venous Thromboembolism (VTE)
  • Von Willebrand Disease
  • Waldenstrom Macroglobulinemia

Best Hematology Doctors in India